THE NEW YORK TIMES MAGAZINE:The 9.20.26 Issue features David Wallace-Wells on our age of perpetual climate disaster; Eve Fairbanks on a superintendent who rebuilt his devestated schools; Mark Chiusano on the New York City subway system and flooding; and more.
A former superintendent in Joplin, Mo., is trying to apply what he learned to other shattered districts — and reckoning with the toll of the disaster on his own life. By Eve Fairbanks
BARRON’S MAGAZINE: The latest issue features ‘The Anthropic Paradox’ – As the AI company’s much-anticipated IPO nears, CEO Dario Amodei faces a stark choice: profits or humanity
John Cochrane, a senior fellow at the Hoover Institution, says that rate cuts will lower inflation only in the short term so long as fiscal policy favors borrowing and spending.
Before the Spanish conquest, the history of the Aztec Empire was recorded orally and with hieroglyphs. In danger of being lost or forgotten, Indigenous historians began to write it down.
In 1938 a sensational spy trial exposed a Nazi plot to seduce and blackmail US officers. Despite America’s technological might, counterintelligence had been slow on the uptake.
Willem de Kooning’s works on paper document his efforts to find ways of retaining both image and abstraction, depth and flatness.
Willem de Kooning Drawing an exhibition at the Art Institute of Chicago, June 14–September 20, 2026, and the Rijksmuseum, Amsterdam, October 9, 2026–January 17, 2027
Charles Lamb’s camp, mischievous, melancholic alter ego, Elia, owes much to his sister, Mary, with whom he lived for forty years, absorbing her “rambling chat.”
Complete Works of Charles and Mary Lamb, Volume IV: Elia and The Last Essays of Elia edited by Gregory Dart
Hard questions about AI in the classroom by Nathalia Alcantara
Mark Brilliant misses plagiarism.
The old kind, that is. Back when his students copied from Wikipedia, and when Turnitin, a text-matching software developed at Berkeley, could match plagiarized paragraphs to their original sources.
Brilliant has taught American history at Berkeley for more than two decades—before that, he taught high school—and for most of that time, catching a cheater was just a routine, though unpleasant, part of the job. What’s different now is not that students cheat. It’s what happens when he catches them.
UC faculty split over standardized test requirement by Margie Cullen
In the spring of 2023, UC Berkeley math professor Zvezdelina Stankova began to notice that about a third of her students were “in freefall.” They weren’t showing up to lectures or doing their homework, and, on tests, they scored far below the average. At first, she thought it was an anomaly, but her observations were reinforced by a 2025 UC San Diego report that found that 1 in 12 of the campus’s incoming students tested below middle school math standards.
The development comes after the UC Board of Regents dispensed with standardized testing as a requirement of admission in 2020. That decision has since caused a rupture between faculty who feel the tests are an important measure of college preparedness and those who feel they discriminate against underrepresented students.
IGI-affiliated researchers have spawned more than 30 startups. Here are just six of them. By James Pagett Tollen
Berkeley Professor Jennifer Doudna, who shared the Nobel Prize for developing the gene-editing tool CRISPR-Cas9, founded the Innovative Genomics Institute in 2015 to advance new applications of the revolutionary technology. Since then, IGI-affiliated researchers have spawned more than 30 startups. Here are just six of them.
Amber Bio
Basem Al-Shayeb, Ph.D. ’22, a graduate of the Banfield and Doudna Labs, cofounded Amber Bio in 2021 to address a limit of the gene-editing field: The current paradigm of genetic medicine relies on developing independent therapies for each separate mutation, the company says. Amber Bio’s RNA-writing platform will enable thousands of mutations to be edited simultaneously. Importantly, the company adds, these RNA-based edits will be reversible.
Editpep
The goal of Editpep, per the company’s website, is straightforward: “To bring life-changing genome-editing therapies to patients with devastating neurological diseases.” They will do so by safely delivering CRISPR straight into the brain. Ross Wilson, IGI’s director of therapeutic delivery and an assistant adjunct professor at Berkeley, cofounded the company in 2023.